Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: A randomized, double blind, parallel group study

Journal of Rheumatology

Volumn 27, Issue 12, 2000, Pages 2791-2797

  Bird, H ^a   Broggini, M ^a  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

Amitriptyline; Depression; Paroxetine; Rheumatoid arthritis; Safety; Tolerability

Indexed keywords

AMITRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHEUMATOID ARTHRITIS; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ARTHRITIS, RHEUMATOID; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; TREATMENT OUTCOME;

EID: 0033663752     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis
2. Prevalence of self-reported depression in patients with rheumatoid arthritis
3. The psychosocial effects of rheumatoid arthritis on the patient and well partner
4. Depression in rheumatoid arthritis: Aetiology and treatment
5. Risk factors for depression in rheumatoid arthritis
6. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
7. Predictors of functional disability in patients with rheumatoid arthritis
8. The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis
9. Depression in rheumatoid arthritis
10. The implications of depression for pain and disability in rheumatoid arthritis
11. Antidepressant analgesia in rheumatoid arthritis
12. The use of antidepressants in the treatment of chronic pain. A review of the current evidence
13. Antidepressants in the management of chronic pain syndromes
14. Depression in rheumatoid arthritis
15. Imipramine, rheumatoid arthritis and rheumatoid factor
16. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders
17. The safety profile of paroxetine
18. Paroxetine in the elderly: A comparative meta-analysis against standard antidepressant pharmacotherapy
19. Paroxetine: A review of clinical experience
20. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
21. A review of the metabolism and pharmacokinetics of paroxetine in man
22. Therapeutic criteria in rheumatoid arthritis
23. A new depression rating scale designed to be sensitive to change
24. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
25. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis
26. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
27. Best clinical practice: Guidelines for managing major depression in primary medical care
28. A five year review of fatal self-ingested overdoses involving amitriptyline in Edinburgh
29. Relative mortality from overdose of antidepressants
30. SSRI safety in overdose